Long Term Investment, Biotech & High Yield Dividend Stocks

[califax]

PDL BioPharma ( PDLI ) - Special Dividend

PDL BioPharma Announces Ex-Dividend Date of September 13 for Special Dividend

Press Release Source: PDL BioPharma, Inc.
Thursday September 9, 2010, 7:00 am EDT

http://finance.yahoo.com/news/PDL-BioPharma-Announces-prnews-144309247.html?x=0&.v=1


INCLINE VILLAGE, Nev., Sept. 9 /PRNewswire-FirstCall/ --

PDL BioPharma, Inc. (PDL) (Nasdaq:PDLI - News) today announced that NASDAQ has established September 13, 2010 as the ex-dividend date for its second of two special dividends to stockholders declared by the Board of Directors on January 27, 2010. The dividend of $0.50 per share will be paid on October 1, 2010 to all stockholders of record on September 15, 2010.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed today based on patents which expire in late 2014. For more information, please visit www.pdl.com